Author:
Barros C. M.,Betts J. G.,Thatcher W. W.,Hansen P. J.
Abstract
ABSTRACT
Experiments were performed to determine the mechanism by which recombinant bovine interferon-αI1 (rbIFN-α) causes an acute reduction in plasma concentrations of progesterone. In experiment 1, administration of a prostaglandin synthesis inhibitor blocked rbIFN-α-induced hyperthermia but did not prevent the decline in plasma concentrations of progesterone. The decline in progesterone concentrations caused by rbIFN-α was, therefore, not a direct consequence of the associated hyperthermia or of pathways mediated through prostaglandin synthesis. It is also unlikely that rbIFN-α acts to increase the clearance of progesterone since injection of rbIFN-α did not decrease plasma concentrations of progesterone in ovariectomized cows given an intravaginal implant of progesterone (experiment 2). In experiment 3, rbIFN-α did not affect basal and LH-induced release of progesterone from cultured luteal slices, indicating that rbIFN-α is unlikely to affect luteal function directly. Injection of rbIFN-α did, however, cause a decrease in plasma concentrations of LH in ovariectomized cows (experiment 4) that coincided temporally with the decrease in progesterone concentrations seen in cows having a functional corpus luteum. The present results strongly suggest that rbIFN-α acts to reduce secretion of progesterone by interfering with pituitary support for luteal synthesis of progesterone. The finding that rbIFN-α can inhibit LH secretion implies that interferon-α molecules should be considered among the cytokines that can regulate hypothalamic or pituitary function.
Journal of Endocrinology (1992) 133, 175–182
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献